248 related articles for article (PubMed ID: 22245114)
41. Identification of novel GNAS mutations in intramuscular myxoma using next-generation sequencing with single-molecule tagged molecular inversion probes.
Bekers EM; Eijkelenboom A; Rombout P; van Zwam P; Mol S; Ruijter E; Scheijen B; Flucke U
Diagn Pathol; 2019 Feb; 14(1):15. PubMed ID: 30736805
[TBL] [Abstract][Full Text] [Related]
42. Fibrous dysplasia of bone and McCune-Albright syndrome.
Chapurlat RD; Orcel P
Best Pract Res Clin Rheumatol; 2008 Mar; 22(1):55-69. PubMed ID: 18328981
[TBL] [Abstract][Full Text] [Related]
43. [Abnormal expression of c-myc, p53, p16 protein and GNAS1 gene mutation in fibrous dysplasia].
Tang J; Zhao HY; Zheng L; Zhang HZ; Jiang ZM
Zhonghua Bing Li Xue Za Zhi; 2009 May; 38(5):292-7. PubMed ID: 19575869
[TBL] [Abstract][Full Text] [Related]
44. The CREB-Smad6-Runx2 axis contributes to the impaired osteogenesis potential of bone marrow stromal cells in fibrous dysplasia of bone.
Fan QM; Yue B; Bian ZY; Xu WT; Tu B; Dai KR; Li G; Tang TT
J Pathol; 2012 Sep; 228(1):45-55. PubMed ID: 22450860
[TBL] [Abstract][Full Text] [Related]
45. Osteoblast-specific expression of the fibrous dysplasia (FD)-causing mutation Gsα(R201C) produces a high bone mass phenotype but does not reproduce FD in the mouse.
Remoli C; Michienzi S; Sacchetti B; Consiglio AD; Cersosimo S; Spica E; Robey PG; Holmbeck K; Cumano A; Boyde A; Davis G; Saggio I; Riminucci M; Bianco P
J Bone Miner Res; 2015 Jun; 30(6):1030-43. PubMed ID: 25487351
[TBL] [Abstract][Full Text] [Related]
46. The histopathology of fibrous dysplasia of bone in patients with activating mutations of the Gs alpha gene: site-specific patterns and recurrent histological hallmarks.
Riminucci M; Liu B; Corsi A; Shenker A; Spiegel AM; Robey PG; Bianco P
J Pathol; 1999 Jan; 187(2):249-58. PubMed ID: 10365102
[TBL] [Abstract][Full Text] [Related]
47. A disruptive mutation in exon 3 of the GNAS gene with albright hereditary osteodystrophy, normocalcemic pseudohypoparathyroidism, and selective long transcript variant Gsalpha-L deficiency.
Thiele S; Werner R; Ahrens W; Hoppe U; Marschke C; Staedt P; Hiort O
J Clin Endocrinol Metab; 2007 May; 92(5):1764-8. PubMed ID: 17299070
[TBL] [Abstract][Full Text] [Related]
48. [Fibrous dysplasia of bone in a young male].
Alonso G; Muñoz-Torres M
Endocrinol Nutr; 2009 Apr; 56(4):195-200. PubMed ID: 19627736
[TBL] [Abstract][Full Text] [Related]
49. Direct evidence for the age-dependent demise of GNAS-mutated cells in oral fibrous dysplasia.
Isobe Y; Takahashi K; Kiso H; Nakao K; Ikeno M; Koyama N; Sugai M; Shimizu A; Haga H; Bessho K
Arch Oral Biol; 2018 Sep; 93():133-140. PubMed ID: 29909118
[TBL] [Abstract][Full Text] [Related]
50. Natural history and treatment of fibrous dysplasia of bone: a multicenter clinicopathologic study promoted by the European Pediatric Orthopaedic Society.
Ippolito E; Bray EW; Corsi A; De Maio F; Exner UG; Robey PG; Grill F; Lala R; Massobrio M; Pinggera O; Riminucci M; Snela S; Zambakidis C; Bianco P;
J Pediatr Orthop B; 2003 May; 12(3):155-77. PubMed ID: 12703030
[TBL] [Abstract][Full Text] [Related]
51. A mouse model of albright hereditary osteodystrophy generated by targeted disruption of exon 1 of the Gnas gene.
Germain-Lee EL; Schwindinger W; Crane JL; Zewdu R; Zweifel LS; Wand G; Huso DL; Saji M; Ringel MD; Levine MA
Endocrinology; 2005 Nov; 146(11):4697-709. PubMed ID: 16099856
[TBL] [Abstract][Full Text] [Related]
52. Selective deficiency of Gsalpha and the possible role of alternative gene products of GNAS in Albright hereditary osteodystrophy and pseudohypoparathyroidism type Ia.
Thiele S; Werner R; Ahrens W; Hübner A; Hinkel KG; Höppner W; Igl B; Hiort O
Exp Clin Endocrinol Diabetes; 2010 Feb; 118(2):127-32. PubMed ID: 19658058
[TBL] [Abstract][Full Text] [Related]
53. Activating Gs(alpha) mutation in intramuscular myxomas with and without fibrous dysplasia of bone.
Okamoto S; Hisaoka M; Ushijima M; Nakahara S; Toyoshima S; Hashimoto H
Virchows Arch; 2000 Aug; 437(2):133-7. PubMed ID: 10993273
[TBL] [Abstract][Full Text] [Related]
54. Expression of an active Gα
Zhao X; Deng P; Iglesias-Bartolome R; Amornphimoltham P; Steffen DJ; Jin Y; Molinolo AA; de Castro LF; Ovejero D; Yuan Q; Chen Q; Han X; Bai D; Taylor SS; Yang Y; Collins MT; Gutkind JS
Proc Natl Acad Sci U S A; 2018 Jan; 115(3):E428-E437. PubMed ID: 29282319
[TBL] [Abstract][Full Text] [Related]
55. GNAS mutations are not detected in parosteal and low-grade central osteosarcomas.
Salinas-Souza C; De Andrea C; Bihl M; Kovac M; Pillay N; Forshew T; Gutteridge A; Ye H; Amary MF; Tirabosco R; Toledo SR; Baumhoer D; Flanagan AM
Mod Pathol; 2015 Oct; 28(10):1336-42. PubMed ID: 26248895
[TBL] [Abstract][Full Text] [Related]
56. Searching for somatic mutations in McCune-Albright syndrome: a comparative study of the peptidic nucleic acid versus the nested PCR method based on 148 DNA samples.
Kalfa N; Philibert P; Audran F; Ecochard A; Hannon T; Lumbroso S; Sultan C
Eur J Endocrinol; 2006 Dec; 155(6):839-43. PubMed ID: 17132753
[TBL] [Abstract][Full Text] [Related]
57. [Fibrous dysplasia of bone].
Sone T
Nihon Rinsho; 2006 Jun; Suppl 2():148-51. PubMed ID: 16817371
[No Abstract] [Full Text] [Related]
58. Quantitative and sensitive detection of GNAS mutations causing mccune-albright syndrome with next generation sequencing.
Narumi S; Matsuo K; Ishii T; Tanahashi Y; Hasegawa T
PLoS One; 2013; 8(3):e60525. PubMed ID: 23536913
[TBL] [Abstract][Full Text] [Related]
59. Genetic and molecular aspects of McCune-Albright syndrome.
Lietman SA; Schwindinger WF; Levine MA
Pediatr Endocrinol Rev; 2007 Aug; 4 Suppl 4():380-5. PubMed ID: 17982384
[TBL] [Abstract][Full Text] [Related]
60. Pseudohypoparathyroidism and GNAS epigenetic defects: clinical evaluation of albright hereditary osteodystrophy and molecular analysis in 40 patients.
Mantovani G; de Sanctis L; Barbieri AM; Elli FM; Bollati V; Vaira V; Labarile P; Bondioni S; Peverelli E; Lania AG; Beck-Peccoz P; Spada A
J Clin Endocrinol Metab; 2010 Feb; 95(2):651-8. PubMed ID: 20061437
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
